Draper Triangle

Draper Triangle is a venture capital firm founded in 1999, specializing in early-stage investments. Based in Pittsburgh, Pennsylvania, with additional offices in Midwest states, the firm focuses on technology companies, particularly in software, digital media, robotics, and medical devices. Draper Triangle seeks to invest between $250,000 and $2 million initially, aiming for companies with high growth potential.

Thompson Jones

Managing Director

Zach Malone

Principal

Jonathan Murray

Venture Partner

Past deals in Pennsylvania

Locomation

Venture Round in 2020
Locomation develops an AI-driven trucking technology platform that combines autonomy with driver augmentation. Its Autonomous Relay Convoy system enables trucks to follow a lead vehicle autonomously, enhancing safety and efficiency while reducing operational costs.

Ikos

Venture Round in 2019
Ikos Holdings Co. operates an online platform that connects landlords and renters, streamlining the rental experience for both parties. Founded in 2017 and based in Pittsburgh, Pennsylvania, the company offers a flexible on-demand leasing service for investors while utilizing data analysis to guide client investments. By simplifying the rental process, Ikos helps landlords and renters make informed decisions, fostering transparency and adaptability in their interactions. The platform aims to enhance the way individuals engage with rental properties, ultimately benefiting the real estate market.

Babel Health

Series A in 2019
Babel Health, LLC is a developer of a cloud-based risk adjustment platform tailored for government-sponsored health programs. Founded in 2014 and headquartered in Pittsburgh, Pennsylvania, the company offers a Software-as-a-Service solution that facilitates compliant submissions for various health data processing systems, including the encounter data processing system and risk adjustment payment system. Babel Health's platform features a user-friendly Extract, Transform, and Load (ETL) tool, which streamlines the navigation, transport, and processing of healthcare data. By providing an integrated suite of risk adjustment software, Babel Health enables mid-size health plans to effectively manage and access complex data processes in a cost-effective and compliant manner, thereby bridging the gap to new technology platforms in a rapidly changing healthcare landscape.

Locomation

Seed Round in 2018
Locomation develops an AI-driven trucking technology platform that combines autonomy with driver augmentation. Its Autonomous Relay Convoy system enables trucks to follow a lead vehicle autonomously, enhancing safety and efficiency while reducing operational costs.

Containership

Seed Round in 2016
Containership, Inc. is a technology company based in Pittsburgh, Pennsylvania, specializing in cloud-based solutions for container management. Established in 2015, it operates a Platform-as-a-Service that facilitates continuous delivery systems for containerized applications. The company provides an open-source Docker hosting platform that enables users to deploy applications, schedule clusters, and discover services efficiently. Additionally, Containership offers a hosted service that includes features such as automated provisioning, marketplace integrations, load balancing, and cluster snapshots. Its solutions are designed to fully automate, scale, and deliver applications across various cloud environments and data centers, allowing for seamless expansion and migration.

Acrobatiq

Series A in 2015
Acrobatiq is a developer of a learning optimization platform that enhances teaching and learning through data-driven, personalized solutions. Backed by Carnegie Mellon University, the company leverages pioneering research from the Open Learning Initiative to help educational institutions improve learning outcomes while reducing costs. Its platform provides online authoring tools, templates, and assessment libraries that facilitate the collaborative development of adaptive eLearning courses. By enabling the rapid creation, delivery, and evaluation of customized learning experiences, Acrobatiq empowers educators with insights into student performance, identifying who is succeeding and who requires additional support. This integration of learning science, technology, and data aims to support more students in achieving success in an increasingly credential-driven landscape.

RE2 Robotics

Series A in 2014
RE2 Robotics, based in Pittsburgh, Pennsylvania, is a Carnegie Mellon University spin-off founded in 2001 by Jorgen Pedersen. The company specializes in the development of intelligent mobile manipulation systems that enhance remote interaction with various environments, including ground, aerial, and underwater settings. Its innovative robotic technologies are designed to improve safety and efficiency across multiple industries, including aviation, construction, defense, energy, and medical sectors. RE2 Robotics primarily serves military clients, having deployed over 400 robotic arms for explosive ordnance disposal missions. The company's intuitive systems and advanced autonomy capabilities enable users to perform dangerous tasks remotely, thereby enhancing worker safety and reducing operational costs.

Rhiza

Series A in 2014
Rhiza, Inc. is a company that specializes in online marketing analytics, providing a platform designed to make big data actionable for marketers and sales professionals. Founded in 2008 and based in Pittsburgh, Pennsylvania, with an additional office in Seattle, Rhiza's software enables media companies to gain insights into their audiences, content, and advertisers by visualizing and analyzing disparate data sets. This functionality supports the optimization of targeted media buys, tracking of campaign effectiveness, and the development of new marketing strategies. Rhiza's solutions empower media publishers to enhance their ad sales capabilities and provide advertisers with the tools needed to maximize their marketing investments. The company operates as a subsidiary of Nielsen Holdings plc and serves notable clients, including major media brands like BBC Worldwide and Comcast.

BodyMedia

Venture Round in 2012
BodyMedia, founded in 1999 and based in Pittsburgh, Pennsylvania, specializes in the development of wearable body monitoring devices that collect physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology, clinically validated for accuracy. BodyMedia's devices assist both consumers and health professionals in making informed behavioral changes to manage weight and promote an active lifestyle, which are critical in addressing various medical conditions. The company has developed one of the largest databases of human physiological information, with its technology being utilized in over 100 clinical research studies related to health issues such as obesity, diabetes, and sleep disorders. Additionally, BodyMedia provides metabolic assessment and behavioral therapy services aimed at treating obesity and cardiovascular diseases, along with calorie management systems that help users track and compare calories burned with those consumed.

Helomics Corporation

Series D in 2010
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

BitArmor Systems

Series B in 2009
BitArmor Systems was a security software company located in Pittsburgh, Pennsylvania, specializing in information-centric data security solutions. The company developed an integrated encryption technology designed to protect data across various devices, catering primarily to mid-market businesses. Its offerings included cloud-based encryption solutions for USB drives, email attachments, and disk encryption, as well as file and disk encryption for laptops, desktops, storage servers, and other media. BitArmor's focus on comprehensive data protection positioned it as a notable player in the cybersecurity landscape until its acquisition by Trustwave Holdings, Inc.

Helomics Corporation

Venture Round in 2008
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

BitArmor Systems

Series A in 2008
BitArmor Systems was a security software company located in Pittsburgh, Pennsylvania, specializing in information-centric data security solutions. The company developed an integrated encryption technology designed to protect data across various devices, catering primarily to mid-market businesses. Its offerings included cloud-based encryption solutions for USB drives, email attachments, and disk encryption, as well as file and disk encryption for laptops, desktops, storage servers, and other media. BitArmor's focus on comprehensive data protection positioned it as a notable player in the cybersecurity landscape until its acquisition by Trustwave Holdings, Inc.

Helomics Corporation

Funding Round in 2006
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

Aethon

Series D in 2005
Aethon Inc. is a company that specializes in the development of autonomous mobile delivery robot systems designed for hospitals. Its flagship product, TUG, is an automated robotic delivery system that efficiently transports medications, meals, laboratory specimens, and other materials throughout healthcare facilities. Aethon also offers a suite of software solutions, including MedEx, which ensures chain-of-custody control for medication delivery, and MedSafe, which manages order preparation and courier tracking. Additional products like TraySafe and TubeSafe focus on the automation of medication management and delivery processes. The company's Intralogistics platform enhances internal logistics by automating material movement within hospitals. Founded in 1997 and based in Pittsburgh, Pennsylvania, Aethon aims to improve hospital efficiency, enhance clinical staff effectiveness, and elevate patient satisfaction through its innovative automated solutions. The company was previously known as Probotics Inc. before rebranding to Aethon Inc. in 2001.

BodyMedia

Series E in 2005
BodyMedia, founded in 1999 and based in Pittsburgh, Pennsylvania, specializes in the development of wearable body monitoring devices that collect physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology, clinically validated for accuracy. BodyMedia's devices assist both consumers and health professionals in making informed behavioral changes to manage weight and promote an active lifestyle, which are critical in addressing various medical conditions. The company has developed one of the largest databases of human physiological information, with its technology being utilized in over 100 clinical research studies related to health issues such as obesity, diabetes, and sleep disorders. Additionally, BodyMedia provides metabolic assessment and behavioral therapy services aimed at treating obesity and cardiovascular diseases, along with calorie management systems that help users track and compare calories burned with those consumed.

Renal Solutions

Series B in 2005
Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment, which is designed to improve care for patients suffering from chronic and acute kidney failure. By offering a clinical care model, Renal Solutions enables healthcare practitioners to provide convenient and flexible treatment options that utilize sorbent-based dialysis technology. In November 2007, Renal Solutions was acquired by Fresenius Medical Care, enhancing its capacity to deliver innovative renal care solutions.

Helomics Corporation

Series C in 2003
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

BodyMedia

Series C in 2003
BodyMedia, founded in 1999 and based in Pittsburgh, Pennsylvania, specializes in the development of wearable body monitoring devices that collect physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology, clinically validated for accuracy. BodyMedia's devices assist both consumers and health professionals in making informed behavioral changes to manage weight and promote an active lifestyle, which are critical in addressing various medical conditions. The company has developed one of the largest databases of human physiological information, with its technology being utilized in over 100 clinical research studies related to health issues such as obesity, diabetes, and sleep disorders. Additionally, BodyMedia provides metabolic assessment and behavioral therapy services aimed at treating obesity and cardiovascular diseases, along with calorie management systems that help users track and compare calories burned with those consumed.

Renal Solutions

Series A in 2002
Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment, which is designed to improve care for patients suffering from chronic and acute kidney failure. By offering a clinical care model, Renal Solutions enables healthcare practitioners to provide convenient and flexible treatment options that utilize sorbent-based dialysis technology. In November 2007, Renal Solutions was acquired by Fresenius Medical Care, enhancing its capacity to deliver innovative renal care solutions.

Helomics Corporation

Series B in 2001
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

Helomics Corporation

Series A in 2001
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

BodyMedia

Series A in 2000
BodyMedia, founded in 1999 and based in Pittsburgh, Pennsylvania, specializes in the development of wearable body monitoring devices that collect physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology, clinically validated for accuracy. BodyMedia's devices assist both consumers and health professionals in making informed behavioral changes to manage weight and promote an active lifestyle, which are critical in addressing various medical conditions. The company has developed one of the largest databases of human physiological information, with its technology being utilized in over 100 clinical research studies related to health issues such as obesity, diabetes, and sleep disorders. Additionally, BodyMedia provides metabolic assessment and behavioral therapy services aimed at treating obesity and cardiovascular diseases, along with calorie management systems that help users track and compare calories burned with those consumed.

OnlineChoice

Venture Round in 2000
OnlineChoice is a Pittsburgh-based company founded in August 1999 that leverages the concept of group buying to provide consumers with the best prices on various goods and services, including electricity, natural gas, and communication services. By utilizing an online platform, OnlineChoice aggregates consumers who are interested in saving money, allowing suppliers to reduce marketing costs by selling to a large group instead of individual buyers. This innovative approach not only benefits consumers through lower prices but also streamlines the purchasing process for suppliers, creating a mutually advantageous marketplace.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.